Milestone Scientific, Inc.

187 articles with Milestone Scientific, Inc.

• Milestone Scientific CEO to Participate in Fireside Chat Hosted by Maxim Group and M-Vest on January 20th

  1/18/2022

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments, that provide virtually painless and precise injections, announced that Arjan Haverhals, CEO and president of Milestone Scientific, will participate in a virtual fireside chat hosted by Anthony Vendetti, executive managing director of research at Maxim Group LLC.

• Milestone Scientific Projects Revenue to Increase Over 85% to More than $10 Million for 2021

  1/10/2022

  Milestone Scientific Inc. today provided revenue guidance for the fourth quarter and year ended December 31, 2021.

• Milestone Scientific to Present at the H.C. Wainwright BioConnect 2022 Conference

  1/7/2022

  Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13, 2022.

• Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Prominent Pain Clinic with Leading Physician

  1/6/2022

  Milestone Scientific Inc today announced that Dr. Harsh Govil, MD, MPH, whose practice is based in Statesville, NC, has begun incorporating the CompuFlo ® Epidural instrument into his practice for pain management, following a successful evaluation.

• Milestone Scientific Announces Purchase of CompuFlo / CathCheck™ Verification System Disposables at Two Additional Premier HospitalsBoth hospitals belong to large hospital systems representing future growth opportunities

  12/28/2021

  Milestone Scientific Inc. today announced the purchase of its CompuFlo ® Epidural and CathCheck ™ Verification System disposables from two additional leading hospitals, expanding the Company’s geographic footprint.

• Milestone Scientific Names Andau Medical as an Additional Distributor for the STA Single Tooth Anesthesia System® in North America

  12/23/2021

  Milestone Scientific Inc. today announced it has entered into an agreement with Andau Medical to distribute the STA Single Tooth Anesthesia System ® in the United States and Canada.

• Milestone Scientific Announces Purchase Agreement for its CompuFlo® Epidural / CathCheck™ Verification System Disposables with a Premier Northeast Teaching Hospital

  12/22/2021

  Milestone Scientific Inc. today reported, that following a successful trial, it has signed an agreement for the purchase of its CompuFlo ® Epidural and CathCheck ™ Verification System disposables with a major Northeast teaching hospital, which is part of one of the leading health systems in the United States.

• Milestone Scientific CEO Arjan Haverhals to Participate in the Benzinga All Access Event on December 16th

  12/15/2021

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments, that provide painless and precise injections, announced that Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific, will be participating in the Benzinga All Access event taking place on December 16, 2021.

• Dr. Miguel de la Garza, President of the Florida Society of Interventional Pain Physicians and Renowned Physician at Surgery Partners, Adopts Milestone Scientific’s CompuFlo® Epidural Instrument for Pain Management

  12/1/2021

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments, that provide painless and precise injections, announced that Dr. Miguel de la Garza has begun incorporating the CompuFlo® Epidural instrument into his practice for pain management, following approval by Surgery Partners, one of the largest and growing surgical services business in the country.

• Milestone Scientific Reports 69% Increase in Revenue for Third Quarter of 2021

  11/15/2021

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, provided a business update and announced financial results for the third quarter ended September 30, 2021.

• Milestone Scientific Schedules Third Quarter 2021 Business Update Conference Call

  11/11/2021

  Milestone Scientific Inc. today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, November 15, 2021 to discuss the Company’s financial results for the third quarter ended September 30, 2021, as well as the Company’s corporate progress and other developments.

• Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021

  10/18/2021

  Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific, will present at the Dawson James Securities Small Cap Growth Conference.

• Milestone Scientific to Present at Microcap Rodeo’s Fall Harvest - Best Ideas from the Buy-Side on Wednesday, October 6, 2021

  10/5/2021

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments, that provide painless and precise injections, announced that the Company has been invited to present at the Fall Harvest - Best Ideas from the Buy-Side conference, which is being held virtually on October 5 - 8, 2021.

• Milestone Scientific Approved as Vendor to Supply CompuFlo® Epidural/ CathCheck™ Verification System Across Florida’s Memorial Heathcare System

  10/4/2021

  Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that Memorial Regional Hospital in Hollywood, Fla., has begun the use of the CompuFlo Epidural Instrument.

• Milestone Scientific Reports Fourteen-Fold Increase in Revenue for Second Quarter of 2021

  8/16/2021

  Milestone Scientific Inc today provided a business update and announced financial results for the second quarter ended June 30, 2021.

• Milestone Scientific Schedules Second Quarter 2021 Business Update Conference Call

  8/11/2021

  Milestone Scientific Inc. today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, August 16, 2021 to discuss the Company’s financial results for the second quarter ended June 30, 2021, as well as the Company’s corporate progress and other developments.

• Milestone Scientific Expands Medical Sales Team to Capitalize on Growing Interest in CompuFlo Including Appointment of Senior Industry Sales Executive Chet Trechock as VP of Sales for Medical

  6/23/2021

  Milestone Scientific Inc. today announced that it has expanded its medical sales team including the appointment of Chet Trechock as VP of Sales Medical.

• Milestone Scientific to Participate in the Summer Solstice Conference - Best Ideas from the Buy-Side on June 2nd

  5/27/2021

  Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug instruments that provide painless and precise injections, has been invited to present at the "Summer Solstice – Best Ideas from the Buy-Side" conference, which is being held virtually on June 1 st  – 4 th , 2021. Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific, is scheduled to present on Wednesday, June 2 nd , 2021 at 2:00 PM

• Milestone Scientific Reports a 61% Increase in Revenue for Q1 2021

  5/17/2021

  Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the first quarter ended March 31, 2021.

• Milestone Scientific Announces Promotion of Arjan Haverhals to CEO

  5/13/2021

  Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that in connection with the Company’s previously disclosed succession plan: Leonard Osser announced his intention to resign as Interim Chief Executive Officer